{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:22:30Z","timestamp":1769556150198,"version":"3.49.0"},"reference-count":66,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDR"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Tuberculosis (TB) has become a rising concern in low-income countries,\nparticularly in those with Human Immuno Deficiency Virus (HIV) epidemics, and type 2 diabetes\nhas emerged as a significant global chronic health problem, owing to increases in obesity, lifestyle\nchanges, and ageing populations. Diabetes has been identified as a major risk factor for the development\nof TB. Despite the fact that diabetes imparts a substantially lower risk of TB (3-fold) as\ncompared to HIV (&gt;20-fold), in communities where the number of DM patients is high, the contribution\nof diabetes to TB might be bigger than HIV.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>This review will focus on the link between TB and diabetes, which is now one of the\nmost important topics for physicians since diabetes impacts the clinical presentation and outcome\nof TB and vice versa.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Though TB is more common in type 1 diabetes, the extent of the problem in type 2 diabetes\nshould be taken into account with equal care, as type 2 diabetes affects a substantially higher\nnumber of individuals.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions:<\/jats:title>\n<jats:p>Diabetes patients are more vulnerable to infections because of their impaired immune\nsystems. Increased glucose level leads to a rise in the infection status among TB patients and\nalso leads to a rise in various complications. Extensive and increased screening for both TB and\nDM over years can help diagnose disease priorly and help in better management. TB, when diagnosed\nin its early stages, can be easily eradicated.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573399819666230331113156","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T18:57:11Z","timestamp":1680289031000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Diabetes and TB: Confluence of Two Epidemic and Its Effect on Clinical\nPresentation"],"prefix":"10.2174","volume":"20","author":[{"given":"Kumudha","family":"Dhamotharaswamy","sequence":"first","affiliation":[{"name":"Karpagam Academy of Higher Education, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6698-8179","authenticated-orcid":true,"given":"Hemalatha","family":"Selvaraj","sequence":"additional","affiliation":[{"name":"Nandha College of Pharmacy, Erode, Tamil Nadu,\nIndia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padmashree","family":"Lakshmanaperumal","sequence":"additional","affiliation":[{"name":"Nandha College of Pharmacy, Erode, Tamil Nadu,\nIndia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harsha","family":"R.","sequence":"additional","affiliation":[{"name":"Nandha College of Pharmacy, Erode, Tamil Nadu,\nIndia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuja S.","family":"Sasankan","sequence":"additional","affiliation":[{"name":"Nandha College of Pharmacy, Erode, Tamil Nadu,\nIndia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabha","family":"Thangavelu","sequence":"additional","affiliation":[{"name":"Nandha College of Pharmacy, Erode, Tamil Nadu,\nIndia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menaka","family":"K.","sequence":"additional","affiliation":[{"name":"Nandha College of Pharmacy, Erode, Tamil Nadu,\nIndia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sivakumar","family":"Thangavel","sequence":"additional","affiliation":[{"name":"Nandha College of Pharmacy, Erode, Tamil Nadu,\nIndia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1741-7015-9-81","volume":"9","author":"Baker M.A.","year":"2011","unstructured":"Baker M.A.; Harries A.D.; Jeon C.Y.; The impact of diabetes on tuberculosis treatment outcomes: A systematic review. BMC Med  2011,9(1),81","journal-title":"BMC Med"},{"key":"ref=2","unstructured":"TB Available from:  https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/TB(accessed 2021-12-20)."},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijid.2017.01.018","volume":"56","author":"Girardi E.","year":"2017","unstructured":"Girardi E.; Sa\u00f1\u00e9 Schepisi M.; Goletti D.; The global dynamics of diabetes and tuberculosis: the impact of migration and policy implications. Int J Infect Dis  2017,56,45-53","journal-title":"Int J Infect Dis"},{"key":"ref=4","unstructured":"Diabetes. Available from:  https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes(Accessed on: 2021-12-20)"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/j.1365-3156.2010.02625.x","volume":"15","author":"Ruslami R.","year":"2010","unstructured":"Ruslami R.; Aarnoutse R.E.; Alisjahbana B.; Van Der Ven A.J.A.M.; Van Crevel R.; Implications of the global increase of diabetes for tuberculosis control and patient care. Trop Med Int Health  2010,15(11),1289-1299","journal-title":"Trop Med Int Health"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e000666","DOI":"10.1136\/bmjopen-2011-000666","volume":"2","author":"Dobler C.C.","year":"2012","unstructured":"Dobler C.C.; Flack J.R.; Marks G.B.; Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study. BMJ Open  2012,2(1),e000666","journal-title":"BMJ Open"},{"key":"ref=7","first-page":"79","volume":"19","author":"Rao P.V.","year":"1999","unstructured":"Rao P.V.; Persons with type 2 diabetes and co-morbid active tuberculosis should be treated with insulin. Int J Diab Dev Countries  1999,19,79-86","journal-title":"Int J Diab Dev Countries"},{"key":"ref=8","first-page":"83","volume":"29","author":"Rajalakshmi S.","year":"1999","unstructured":"Rajalakshmi S.; Yugi\u2019s pramegam and diebetes mellitus: An analogue. Bull Indian Inst Hist Med Hyderabad  1999,29(1),83-87","journal-title":"Bull Indian Inst Hist Med Hyderabad"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/2251-6581-12-58","volume":"12","author":"Baghaei P.","year":"2013","unstructured":"Baghaei P.; Marjani M.; Javanmard P.; Tabarsi P.; Masjedi M.R.; Diabetes mellitus and tuberculosis facts and controversies. J Diabetes Metab Disord  2013,12(1),58","journal-title":"J Diabetes Metab Disord"},{"key":"ref=10","unstructured":"IDF Diabetes Atlas. sixth. Brussels IDF Available from:  https:\/\/scholar.google.com\/scholar?hl=enandas_sdt=0%2C5andq=IDF.+IDF+Diabetes+Atlas.+sixth.+Brussels%3A+International+Diabetes+Federation%3B+2013.andbtnG=(accessed 2021-12-20)."},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"e000473","DOI":"10.1136\/bmjgh-2017-000473","volume":"2","author":"Gassasse Z.","year":"2017","unstructured":"Gassasse Z.; Smith D.; Finer S.; Gallo V.; Association between urbanisation and type 2 diabetes: An ecological study. BMJ Glob Health  2017,2(4),e000473","journal-title":"BMJ Glob Health"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/7273935","volume":"2016","author":"Siddiqui A.N.","year":"2016","unstructured":"Siddiqui A.N.; Khayyam K.U.; Sharma M.; Effect of Diabetes Mellitus on tuberculosis treatment outcome and adverse reactions in patients receiving directly observed treatment strategy in India: A prospective study. BioMed Res Int  2016,2016,1-11","journal-title":"BioMed Res Int"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S2213-8587(14)70110-X","volume":"2","author":"Riza A.L.","year":"2014","unstructured":"Riza A.L.; Pearson F.; Ugarte-Gil C.; Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol  2014,2(9),740-753","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","volume":"27","author":"Wild S.","year":"2004","unstructured":"Wild S.; Roglic G.; Green A.; Sicree R.; King H.; Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care  2004,27(5),1047-1053","journal-title":"Diabetes Care"},{"key":"ref=15","year":"2000","unstructured":"Internal medicine. Major Complications of Diabetes Mellitus in Africa.  Available from:  pascal-francis.inist.fr2000"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"4.6.48","DOI":"10.1128\/microbiolspec.TNMI7-0023-2016","volume":"4","author":"Restrepo BI","year":"2016","unstructured":"Restrepo BI;  Diabetes and tuberculosis Microbiol Spectr  2016,4(6),4.6.48","journal-title":"Diabetes and tuberculosis Microbiol Spectr"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e93397","DOI":"10.1371\/journal.pone.0093397","volume":"9","author":"Chiang C.Y.","year":"2014","unstructured":"Chiang C.Y.; Lee J.J.; Chien S.T.; Glycemic control and radiographic manifestations of tuberculosis in diabetic patients. PLoS One  2014,9(4),e93397","journal-title":"PLoS One"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1086\/519841","volume":"45","author":"Alisjahbana B.","year":"2007","unstructured":"Alisjahbana B.; Sahiratmadja E.; Nelwan E.J.; The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis  2007,45(4),428-435","journal-title":"Clin Infect Dis"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1530\/EDM-16-0035","volume":"2016","author":"Sol\u00e1 E.","year":"2016","unstructured":"Sol\u00e1 E.; Rivera C.; Mangual M.; Martinez J.; Rivera K.; Fernandez R.; Diabetes mellitus: an important risk factor for reactivation of tuberculosis. Endocrinol Diabetes Metab Case Rep  2016,2016,16-0035","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref=20","unstructured":"Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of TB-National Prevention Information Network-Connecting public health professionals with trusted information and each other.  Available from:  https:\/\/npin.cdc.gov\/publication\/updated-guidelines-use-nucleic-acid-amplification-tests-diagnosis-TB(Accessed on: 2021-12-20)"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"p. PA2973","DOI":"10.1183\/13993003.congress-2019.PA2973","author":"Christopher D.J.","year":"2019","unstructured":"Christopher D.J.; Cherian Kuruvilla L.; Sarangi P.K.; Thangakunam B.; Irodi A.; Shankar D.; chest radiologic pattern in diabetic patients without pulmonary TB (PTB).TB. European Respiratory Society  2019,p. PA2973"},{"key":"ref=22","first-page":"144","volume":"42","author":"Mahishale V.","year":"2017","unstructured":"Mahishale V.; Avuthu S.; Patil B.; Effect of poor glycemic control in newly diagnosed patients with smear-positive pulmonary tuberculosis and Type-2 Diabetes Mellitus. Iran J Med Sci  2017,42(2),144-151","journal-title":"Iran J Med Sci"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4269\/ajtmh.2009.80.634","volume":"80","author":"Dooley K.","year":"2009","unstructured":"Dooley K.; Tang T.; Golub J.; Impact of diabetes mellitus on treatment outcomes of patients with active TB. Am J Trop Med Hyg  2009,80(4),634-639","journal-title":"Am J Trop Med Hyg"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"bcr0920080994","DOI":"10.1136\/bcr.09.2008.0994","volume":"16","author":"Pimazoni A.","year":"2009","unstructured":"Pimazoni A.; The Impact of TB treatment on glycaemic control and the significant response to rosiglitazone. Case Reports  2009,16,bcr0920080994","journal-title":"Case Reports"},{"key":"ref=25","first-page":"3","volume":"47","author":"Amrit G.","year":"2000","unstructured":"Amrit G.; Tuberculosis and diabetes: An appraisal. Indian J Tuberculosis  2000,47(1),3-8","journal-title":"Indian J Tuberculosis"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/2050640620902353","volume":"8","author":"Panic N.","year":"2020","unstructured":"Panic N.; Maetzel H.; Bulajic M.; Radovanovic M.; L\u00f6hr J.M.; Pancreatic T.B.; Pancreatic tuberculosis: A systematic review of symptoms, diagnosis and treatment. United European Gastroenterol J  2020,8(4),396-402","journal-title":"United European Gastroenterol J"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1365-2249.2005.02677.x","volume":"139","author":"Yamashiro S.","year":"2004","unstructured":"Yamashiro S.; Kawakami K.; Uezu K.; Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol  2004,139(1),57-64","journal-title":"Clin Exp Immunol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","volume":"26","author":"Geerlings S.","year":"1999","unstructured":"Geerlings S.; Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol  1999,26(3-4),259-265","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/eji.201344301","volume":"44","author":"Martinez N","year":"2014","unstructured":"Martinez N; Kornfeld H; Diabetes and immunity to Tuberculosis. Eur J Immunol  2014,44(3),617-26","journal-title":"Eur J Immunol"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S1472-9792(13)70004-0","volume":"93","author":"Restrepo B.","year":"2013","unstructured":"Restrepo B.; Host-pathogen interactions in TB patients with Type 2 Diabetes Mellitus. Tuberculosis  2013,93,S10-S14","journal-title":"Tuberculosis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6196532","volume":"2019","author":"Ayelign B.","year":"2019","unstructured":"Ayelign B.; Negash M.; Genetu M.; Wondmagegn T.; Shibabaw T.; Immunological impacts of diabetes on the susceptibility of mycobacterium tuberculosis. J Immunol Res  2019,2019,1-8","journal-title":"J Immunol Res"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/infdis\/jiw436","volume":"214","author":"Martinez N.","year":"2016","unstructured":"Martinez N.; Ketheesan N.; Impaired recognition of mycobacterium tuberculosis by alveolar macrophages from diabetic mice. J Infect Dis  2016,214(11),1629-1637","journal-title":"J Infect Dis"},{"key":"ref=33","year":"2016","unstructured":"Immunological Response to Mycobacterium TB Infection in Blood from Type 2 Diabetes Patients. Elsevier  2016"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.3389\/fimmu.2018.02637","volume":"9","author":"Kroon E.E.","year":"2018","unstructured":"Kroon E.E.; Coussens A.K.; Kinnear C.; Neutrophils: Innate effectors of TB resistance? Front Immunol  2018,9(11),2637","journal-title":"Front Immunol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imm.12762","volume":"152","author":"Nathella P.K.","year":"2017","unstructured":"Nathella P.K.; Immunology S.B.; Influence of Diabetes Mellitus on Immunity to Human TB. Wiley Online Library  2017,152(1),13-24","journal-title":"Wiley Online Library"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/eji.201545973","volume":"46","author":"Kumar N.P.","year":"2016","unstructured":"Kumar N.P.; Moideen K.; George P.J.; Dolla C.; Kumaran P.; Babu S.; Coincident diabetes mellitus modulates Th1-, Th2-, and Th17-cell responses in latent tuberculosis in an IL-10- and TGF-\u03b2-dependent manner. Eur J Immunol  2016,46(2),390-399","journal-title":"Eur J Immunol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2249.2009.04000.x","volume":"158","year":"2009","unstructured":"Al-Attiyah R. Mycobacterial Antigen-induced T Helper Type 1 (Th1) and Th2 Reactivity of Peripheral Blood Mononuclear Cells from Diabetic and Non-diabetic TB Patients. Wiley Online Library  2009,158,64-73","journal-title":"Wiley Online Library"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5588\/ijtld.12.0797","volume":"17","author":"L\u00f6nnroth K.","year":"2013","unstructured":"L\u00f6nnroth K.; Corbett E.; Golub J.; Systematic screening for active tuberculosis: rationale, definitions and key considerations. State of the art series Active case finding\/screening Number 1 in the series  2013,17(3),289-298","journal-title":"State of the art series Active case finding\/screening Number 1 in the series"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4093\/dmj.2013.37.4.291","volume":"37","author":"Jali M.","year":"2013","unstructured":"Jali M.; Mahishale V.K.; Hiremath M.B.; Bidirectional Screening of TB Patients for Diabetes Mellitus and Diabetes Patients for TB. Diabetes Metab J  2013,37(4),291","journal-title":"Diabetes Metab J"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.5588\/ijtld.11.0503","volume":"15","author":"Harries A.D.","year":"2011","unstructured":"Harries A.D.; Lin Y.; Satyanarayana S.; The looming epidemic of diabetes-associated TB: Learning lessons from HIV-Associated TB. Int J TB Lung Dis  2011,15(11),1436-1445","journal-title":"Int J TB Lung Dis"},{"key":"ref=41","first-page":"399","volume":"57","author":"Sen T.","year":"2009","unstructured":"Sen T.; Joshi S.R.; Udwadia Z.F.; Tuberculosis and diabetes mellitus: Merging epidemics. J Assoc Physicians India  2009,57,399-404","journal-title":"J Assoc Physicians India"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/j.1365-3156.2012.03069.x","volume":"17","author":"Lin Y.","year":"2012","unstructured":"Lin Y.; Li L.; Mi F.; Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health  2012,17(10),1302-1308","journal-title":"Trop Med Int Health"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/tmi.12083","volume":"18","year":"2013","unstructured":"Screening of patients with diabetes mellitus for tuberculosis in India. Trop Med Int Health  2013,18(5),646-654","journal-title":"Trop Med Int Health"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/infdis\/jiu329","volume":"210","author":"Kumar N.P.","year":"2014","unstructured":"Kumar N.P.; George P.J.; Kumaran P.; Dolla C.K.; Nutman T.B.; Babu S.; Diminished systemic and antigen-specific type 1, type 17, and other proinflammatory cytokines in diabetic and prediabetic individuals with latent Mycobacterium tuberculosis infection. J Infect Dis  2014,210(10),1670-1678","journal-title":"J Infect Dis"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","volume":"167","author":"Lu L.L.","year":"2016","unstructured":"Lu L.L.; Chung A.W.; Rosebrock T.R.; A functional role for antibodies in tuberculosis. Cell  2016,167(2),433-443","journal-title":"Cell"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09247","volume":"466","author":"Berry M.P.R.","year":"2010","unstructured":"Berry M.P.R.; Graham C.M.; McNab F.W.; An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature  2010,466(7309),973-977","journal-title":"Nature"},{"key":"ref=47","first-page":"127","volume":"43","author":"Nwabudike L.","year":"2005","unstructured":"Nwabudike L.; Intradermal reactions to purified protein derivative in patients with diabetes mellitus. Rom J Intern Med  2005,43(1-2),127-132","journal-title":"Rom J Intern Med"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S2213-8587(14)70109-3","volume":"2","author":"L\u00f6nnroth K.","year":"2014","unstructured":"L\u00f6nnroth K.; Roglic G.; Harries A.D.; Improving T.B.; Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice. Lancet Diabetes Endocrinol  2014,2(9),730-739","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref=49","first-page":"9","year":"2018","unstructured":"Latent tuberculosis infection updated and consolidated guidelines for programmatic management. WHO Guidelines approved by the Guidelines Review Committee. Geneva: World Helath Organization  2018,9-29","journal-title":"World Helath Organization"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.3389\/fimmu.2020.02006","volume":"11","author":"Carranza C.","year":"2020","unstructured":"Carranza C.; Pedraza-Sanchez S.; de Oyarzabal-Mendez E.; Torres M.; Diagnosis for latent tuberculosis infection: new alternatives. Front Immunol  2020,11,2006","journal-title":"Front Immunol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/tropicalmed6010008","volume":"86","author":"van Crevel R","year":"2021","unstructured":"van Crevel R; Critchley JA; The interaction of diabetes and tuberculosis: translating research to policy and practice. Trop Med Infecti\tDis  2021,86(1),8","journal-title":"Trop Med Infecti\tDis"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/2251-6581-11-28","volume":"11","author":"Niazi A.K.","year":"2012","unstructured":"Niazi A.K.; Kalra S.; Diabetes and tuberculosis: a review of the role of optimal glycemic control. J Diabetes Metab Disord  2012,11(1),28","journal-title":"J Diabetes Metab Disord"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/resp.13017","volume":"22","author":"Leung C.C.","year":"2017","unstructured":"Leung C.C.; Yew W.W.; Mok T.Y.W.; Effects of diabetes mellitus on the clinical presentation and treatment response in tuberculosis. Respirology  2017,22(6),1225-1232","journal-title":"Respirology"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1093\/jac\/dkz368","volume":"74","author":"Mtabho C.M.","year":"2019","unstructured":"Mtabho C.M.; Semvua H.H.; van den Boogaard J.; Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients. J Antimicrob Chemother  2019,74(12),3537-3545","journal-title":"J Antimicrob Chemother"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1086\/507543","volume":"43","author":"Nijland H.M.J.","year":"2006","unstructured":"Nijland H.M.J.; Ruslami R.; Stalenhoef J.E.; Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes. Clin Infect Dis  2006,43(7),848-854","journal-title":"Clin Infect Dis"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1128\/AAC.00447-09","volume":"54","author":"Ruslami R.","year":"2010","unstructured":"Ruslami R.; Nijland H.M.J.; Adhiarta I.G.N.; Pharmacokinetics of AntiTB drugs in pulmonary TB patients with Type 2 Diabetes. Antimicrob Agents Chemother  2010,54(3),1068-1074","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"e92623","DOI":"10.1371\/journal.pone.0092623","volume":"9","author":"Lee P.H.","year":"2014","unstructured":"Lee P.H.; Lin H.C.; Huang A.S.E.; Wei S.H.; Lai M.S.; Lin H.H.; Diabetes and risk of tuberculosis relapse: Nationwide nested case-control study. PLoS One  2014,9(3),e92623","journal-title":"PLoS One"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"574","DOI":"10.2105\/AJPH.87.4.574","volume":"87","author":"Pablos-M\u00e9ndez A.","year":"1997","unstructured":"Pablos-M\u00e9ndez A.; Blustein J.; Knirsch C.A.; The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health  1997,87(4),574-579","journal-title":"Am J Public Health"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1371\/journal.pmed.0050181","volume":"5","author":"Jeon C.Y.","year":"2008","unstructured":"Jeon C.Y.; Murray M.B.; Correction: Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies. PLoS Med  2008,5(8),e181","journal-title":"PLoS Med"},{"key":"ref=60","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.73601","author":"Naidoo K.","year":"2018","unstructured":"Naidoo K.; Dookie N.; Insights into Recurrent TB: Relapse Versus Reinfection and Related Risk Factors. In: TB InTech  2018","journal-title":"In: TB InTech"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13643-018-0828-0","volume":"7","author":"Tegegne B.S.","year":"2018","unstructured":"Tegegne B.S.; Mengesha M.M.; Teferra A.A.; Awoke M.A.; Habtewold T.D.; Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis. Syst Rev  2018,7(1),161","journal-title":"Syst Rev"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2.4.01","DOI":"10.1128\/microbiolspec.MGM2-0014-2013","volume":"2","author":"Vilch\u00e8ze C","year":"2014","unstructured":"Vilch\u00e8ze C; Jacobs WR; Resistance to isoniazid and ethionamide in Mycobacterium tuberculosis : Genes, mutations, and causalities.\tMicrobiol Spectr  2014,2(4),2.4.01"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","volume":"161","year":"2000","unstructured":"Targeted tuberculin testing and treatment of latent TB infection. Am J Respir Crit Care Med  2000,161(suppl. 3),S221-S247","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"CD001363","DOI":"10.1002\/14651858","volume":"1999","author":"Smieja Mj.","year":"2000","unstructured":"Smieja Mj.; Marchetti CA.; Cook DJ.; Smaill F. M.; Isoniazid for Preventing TB in Non-HIV Infected Persons. Cochrane Database of Sys Rev  2000,1999(2),CD001363","journal-title":"Cochrane Database of Sys Rev"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jmii.2018.05.003","volume":"52","author":"Lin S.Y.","year":"2019","unstructured":"Lin S.Y.; Chiu Y.W.; Lu P.L.; Three months of rifapentine and isoniazid for latent tuberculosis infection in hemodialysis patients: High rates of adverse events. J Microbiol Immunol Infect  2019,52(1),158-162","journal-title":"J Microbiol Immunol Infect"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","volume":"365","author":"Sterling T.R.","year":"2011","unstructured":"Sterling T.R.; Villarino M.E.; Borisov A.S.; Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med  2011,365(23),2155-2166","journal-title":"N Engl J Med"}],"container-title":["Current Diabetes Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573399819666230331113156","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/215348\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573399819666230331113156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T17:03:52Z","timestamp":1708621432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/215348\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573399819666230331113156","relation":{},"ISSN":["1573-3998"],"issn-type":[{"value":"1573-3998","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-09-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e310323215348"}}